Independent Research

Cancer prevention research
that doesn't insult your intelligence.

We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments. Every claim gets an evidence grade. No supplements to sell. No miracle cures. Just research.

50+
Clinical trials reviewed
14
Compounds analyzed
A-D
Evidence grading system
$0
Products we sell

Our Evidence Grading System

Every compound and intervention gets a grade based on the quality of human clinical evidence, not animal studies or test tubes.

Grade A
Phase II+ RCT data in humans with positive signal. Real evidence.
Grade B
Phase I/II human data or strong epidemiological evidence. Promising.
Grade C
In vitro / animal data only. Interesting mechanism but unproven in humans.
Debunked
Disproven, retracted research, or actively harmful. Avoid.

Latest Research

Treatment · 12 min read

High-Dose IV Vitamin C: The Trial That Doubled Survival

A Phase II RCT doubled overall survival in metastatic pancreatic cancer. We break down the Iowa trial, mechanism, and what it means.

Grade A: Strong Evidence
Treatment · 10 min read

Mebendazole: The $5 Cancer Drug

An FDA-approved dewormer with Phase I/II trial data in glioblastoma and colorectal cancer. Crosses the blood-brain barrier.

🔬 Grade B: Promising
Early Detection · 8 min read

The Galleri Test: Is $950/yr Worth It?

A blood test that detects 50 cancer types. The PATHFINDER 2 trial showed 7x cancer detection. We analyze what that actually means.

Grade A: Strong Evidence
Prevention · 9 min read

High-Dose Melatonin: The 34% Mortality Reduction

Meta-analysis of 8 RCTs shows melatonin at 10-20mg (not sleep doses) reduced cancer mortality by 34%. No toxicity ever established.

🔬 Grade B: Promising
Treatment · 11 min read

Fenbendazole for Cancer: What the Evidence Actually Shows

The Joe Tippens protocol went viral. But fenbendazole is a vet drug with zero human trials. We separate the hype from the science.

🔶 Grade C: Preclinical Only
Treatment · 10 min read

Ivermectin for Cancer: Separating Signal from Noise

Strong preclinical data across multiple cancer types. First human trials underway. But the dosing question remains unanswered.

🔶 Grade C: Preclinical Only
Treatment · 9 min read

Itraconazole: The Antifungal That Fights Cancer

Phase II trial data in prostate and lung cancer. Blocks Hedgehog signaling and angiogenesis. $15-30/month generic.

🔬 Grade B: Promising
Debunked · 7 min read

Why Metformin Failed for Cancer

The MA.32 trial (3,649 patients) killed the metformin-cancer hypothesis. HR 1.01. We explain what went wrong with the observational data.

⚠️ Grade D: Weak / Mixed
Protocol · 15 min read

The Anti-Cancer Protocol: Daily, Weekly, Monthly

An evidence-ranked stack of interventions from free (fasting, exercise) to prescription (rapamycin). Every item graded.

Grade A: Strong Evidence

New research reviews every month.

We track clinical trials, emerging compounds, and AI-driven cancer discoveries. Get updates when we publish new evidence reviews.